| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 09/12/2003 | WO2003002522A3 Peptide deformylase inhibitors |
| 09/12/2003 | WO2002009683A3 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 09/12/2003 | CA2478485A1 Method for producing optically active compound |
| 09/12/2003 | CA2477749A1 Artificial receptors, building blocks, and methods |
| 09/11/2003 | US20030171585 Anti-inflammatory compounds |
| 09/11/2003 | US20030171411 Amide derivatives as therapeutic agents |
| 09/11/2003 | US20030171410 2-pyridylmethylamine derivatives useful as fungicides |
| 09/11/2003 | US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 09/11/2003 | US20030171351 2'-substituted 1,1'-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 09/11/2003 | US20030171350 Sulphonamide derivatives |
| 09/11/2003 | US20030171349 Novel muscarinic receptor agonists |
| 09/11/2003 | US20030171341 Method for modulating the activity of a Rho C enzyme, comprising: contacting said Rho C enzyme with an effective amount of a compound of formula 1: |
| 09/11/2003 | US20030171337 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and |
| 09/11/2003 | US20030171210 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst |
| 09/11/2003 | US20030170381 Piezoelectric element and process for production thereof |
| 09/11/2003 | US20030170174 For therapy of diseases, such as parasitic and viral infections, conditions associated with inflammation and infection, and conditions mediated by cell-proliferation or collagen formation; contrast agents |
| 09/11/2003 | US20030168970 Luminescent element material and luminescent element comprising the same |
| 09/10/2003 | EP1341785A2 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE |
| 09/10/2003 | EP1341784A2 Process for making a thrombin inhibitor |
| 09/10/2003 | EP1341780A2 Substituted heterocyclic phthalic acid diamide arthropodicides |
| 09/10/2003 | EP1341769A2 Bacterial gyrase inhibitors and uses thereof |
| 09/10/2003 | EP1341764A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 09/10/2003 | EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 09/10/2003 | EP1341754A1 Substituted anthranilic acids |
| 09/10/2003 | EP1341534A2 Compounds having fungicidal activity and processes to make and use same |
| 09/10/2003 | EP1194401B1 Diacylhydrazine derivatives |
| 09/10/2003 | EP1187856B1 Transition metal complexes and olefin polymerization process |
| 09/10/2003 | EP1140818B1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase |
| 09/10/2003 | EP1020443B1 Process for producing piperazinesulfonamide derivatives and salts thereof |
| 09/10/2003 | EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion |
| 09/10/2003 | EP0984938B1 Cyanoguanidines as cell proliferation inhibitors |
| 09/10/2003 | EP0975710B1 Polymer electroluminescent device |
| 09/10/2003 | EP0942938B1 Supported catalyst system, method for the production and use thereof in olefin polymerization |
| 09/10/2003 | EP0939627B1 Pentafluorobenzenesulfonamides and analogs |
| 09/10/2003 | EP0934264B1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 09/10/2003 | EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 09/10/2003 | EP0896533B1 Pentafluorobenzenesulfonamides and analogs |
| 09/10/2003 | CN1441800A Beta 3 adrenergic agonists |
| 09/10/2003 | CN1441783A Medicine comprising dicyanopyridine derivative |
| 09/10/2003 | CN1441782A N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 09/10/2003 | CN1441775A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 09/10/2003 | CN1441773A Cyclohexylamine derivative as subtype selective NMDA receptor Antagonists |
| 09/10/2003 | CN1440965A Pyridine salt derivative as strong two-photon absorbing material and its prepn process |
| 09/10/2003 | CN1440962A Substituted amino amide salicylate with Fungal killing function and tis prepared intermediate thereof |
| 09/09/2003 | US6617340 N-(substituted glycyl)-pyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
| 09/09/2003 | US6617318 7-substitted tetracyclines are effective against tetracycline-resistant E. coli, S. aureus and E. faecalis strains |
| 09/09/2003 | US6617317 Boronic ester and acid compositions |
| 09/09/2003 | US6617299 Composition and method for bleaching a substrate |
| 09/09/2003 | CA2290712C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components |
| 09/09/2003 | CA2031480C Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity |
| 09/04/2003 | WO2003072548A1 Pyridyl sulfone derivatives as 5-ht receptor antagonists |
| 09/04/2003 | WO2003072547A1 PROCESSES AND INTERMEDIATES USEFUL IN PREPARING β3-ADRENERGIC RECEPTOR AGONISTS |
| 09/04/2003 | WO2003072539A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 09/04/2003 | WO2003072535A2 Substituted hydroxyethylamines |
| 09/04/2003 | WO2003072532A1 Ester compound and medicinal use thereof |
| 09/04/2003 | WO2003072062A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 09/04/2003 | WO2003071861A2 Vanillin biosynthetic pathway enzyme from vanilla planifolia |
| 09/04/2003 | WO2003037891A8 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
| 09/04/2003 | WO2003011860A3 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE |
| 09/04/2003 | WO2002070468A3 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 09/04/2003 | US20030166978 Novel ruthenium complexes and process for preparing alcoholic compounds using these |
| 09/04/2003 | US20030166942 Chemical intermediate |
| 09/04/2003 | US20030166941 Short synthesis of pyridine-based pharmaceutical intermediates |
| 09/04/2003 | US20030166932 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/04/2003 | US20030166931 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents |
| 09/04/2003 | US20030166930 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents |
| 09/04/2003 | US20030166920 Prismatic supramolecules |
| 09/04/2003 | US20030166798 Mixtures of condensation polymers comprising organonitrogen or organosulfur polymers and curing agents, having preferential binding, used for analysis, separation and resolution of racemic mixtures |
| 09/04/2003 | US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases |
| 09/04/2003 | US20030166694 Glycinamides |
| 09/04/2003 | US20030166693 Benzene derivatives and pharmaceutical use thereof |
| 09/04/2003 | US20030166691 Phenylalanine derivatives |
| 09/04/2003 | US20030166690 Use of compounds for decreasing activity of hormone-sensitive |
| 09/04/2003 | US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 09/04/2003 | US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer |
| 09/04/2003 | US20030166668 Substituted heteroarylalkanoic acids |
| 09/04/2003 | US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents |
| 09/04/2003 | US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/04/2003 | US20030166622 Vitamin D derivatives with acyloxy groups in the side chains, process for their production, and the use for the production of pharmaceutical agents |
| 09/04/2003 | US20030166613 A macrocyclic diterpene plant extract for treating viral infections; A computer program product for storing the library information of candidate compounds |
| 09/04/2003 | US20030165623 Copper deposition using copper formate complexes |
| 09/04/2003 | US20030163876 For dyeing hair; efficiency |
| 09/04/2003 | CA2477607A1 Substituted hydroxyethylamines |
| 09/04/2003 | CA2471646A1 Processes and intermediates useful in preparing .beta.3-adrenergic receptor agonists |
| 09/03/2003 | EP1341403A1 Luminescent element material and luminescent element comprising the same |
| 09/03/2003 | EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/03/2003 | EP1340747A1 Process for the preparation of 2-halogene-alkyl nicotinic acid alkyl-esters |
| 09/03/2003 | EP1340746A1 Process for the reduction of 3-heteroaryl-3-oxo-propanoic acid derivatives |
| 09/03/2003 | EP1340744A2 Hiv protease inhibitors |
| 09/03/2003 | EP1339754A1 Multicomponent compositions containing chitosan and methods of preparing same |
| 09/03/2003 | EP1339726A1 Catalyst composition and method of polymerization |
| 09/03/2003 | EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 09/03/2003 | EP1339687A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 09/03/2003 | EP1339686A2 Cyanoguanidine prodrugs |
| 09/03/2003 | EP1339684A1 Mch antagonists and their use in the treatment of obesity |
| 09/03/2003 | EP1339675A1 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds |
| 09/03/2003 | EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 09/03/2003 | EP1339665A1 Nitroderivatives as drugs for diseases having an inflammatory basis |
| 09/03/2003 | EP0984936B1 Cyanoguanidines as cell proliferation inhibitors |
| 09/03/2003 | EP0975588B1 Antipicornaviral compouds, compositions containing them, and methods for their use |